Renalogic News

Renalogic Announces Highly Successful Member Outcomes in 2021

Media Release

Clinical success included holding 99.7% of members from progressing to dialysis

CHICAGO, IL (March 14, 2022) – Renalogic, the leading company helping employers and self-funded health plans fight the human and financial costs of chronic kidney disease, today announced the highly successful results of their clinical services for 2021.

Renalogic works with self-insured clients to identify employees and/or covered members who have been diagnosed with, or are at risk for developing, chronic kidney disease (CKD). Members are risk-stratified and assigned an expert clinical support team to help minimize, and in some cases reverse, the progression of CKD.

Every year, Renalogic’s clinical team reviews the impact of its programs in terms of clinical and cost outcomes.  Today, Renalogic announced these industry-leading results for members enrolled during 2021:

  • 99.7% success rate in preventing progression to Dialysis
  • 91% reduction in ER visits
  • 89% reduction in hospital admissions
  • Average PMPM savings of greater than $500

“We are very proud of the results our clinical team achieved in supporting our client plans’ members,” said Kevin Weinstein, CEO of Renalogic. “Our NCQA certified clinical services create real measurable results, both clinically and financially.  By combining focused analytics, administrative member services, and health coaching and care management, our teams support members in making meaningful changes and navigating the complex world of CKD.”

Renalogic’s clinical services support more than 75 employer-sponsored health plans and their employees and members.  Health plans using Renalogic’s clinical services range in size from 100-25,000 members.

“As an organization, we focus on continual improvement,” said Mark Masson, President, and Chief Operating Officer at Renalogic.  “That means we’re always evaluating the latest clinical research and data science improvements to hone our service offering, from enrollment and recruitment to clinical coaching to administrative member services.  We’re constantly identifying  ways to make a positive impact on our clients’ members’ lives.”

About Renalogic

Founded in 2002, Renalogic helps self-funded plans of all sizes and their U.S-based health plan members reduce the human and financial costs of chronic kidney disease (CKD) and dialysis treatment. We help plans manage dialysis claims costs and work to prevent members from progressing to dialysis. Through our cost containment and population health management solutions, Renalogic is 230% better than commercial plans at identifying undiagnosed CKD, 86% effective at preventing members from kidney failure and delivers 84.5% average savings off contracted rates with our claims repricing. We’ve saved our clients over $780,000,000 and helped stop CKD from progressing for thousands of members.